<DOC>
	<DOCNO>NCT00625872</DOCNO>
	<brief_summary>The plan study focus effect one year Somatropin treatment ( 0.035 mg/kg/d 0.067 mg/kg/d ) short child bear SGA neuromuscular function cognitive performance .</brief_summary>
	<brief_title>Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy</brief_title>
	<detailed_description />
	<criteria>Prepubertal boys 6 10 year age girls 6 9 year age . Birth length and/or birth weightSDS adjust gestational age &lt; 2.0 ( Voigt et al . 2002 , Voigt et al . 2006 Lawrence et al . 1989 ) . Current heightSDS &lt; 2.5 ( Brandt/Reinken 1992 ) parental adjust heightSDS 1 ( Hermanussen Cole 2003 ) . Growth velocity SDS &lt; 0 last year inclusion ( Brandt/Reinken 1988 ) . Severe SGA ( birth weight length &lt; 4 SD ) clinically relevant dysmorphic feature . Severe prematurity ( GA &lt; 32 week gestation ) . Severe perinatal complication like asphyxia , sepsis , necrotizing enterocolitis ( NEC ) , respiratory distress syndrome , associate longterm sequela ( like short bowel syndrome , bronchopulmonary dysplasia ( BPD ) , cerebral palsy etc ) . Inability perform one two leg jump stand position . Prior GH treatment .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>